We are live on ! Find out more
MREO

Mereo BioPharma
MREO

66 hedge funds and large institutions have $305M invested in Mereo BioPharma in 2021 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 17 increasing their positions, 7 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

190% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 10

143% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 7

49% more capital invested

Capital invested by funds: $205M → $305M (+$99.6M)

42% more call options, than puts

Call options by funds: $1.15M | Put options by funds: $810K

40% more funds holding

Funds holding: 47 → 66 (+19)

0.56% more ownership

Funds ownership: 13.13% → 13.69% (+0.56%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
66
Holders Change
+19
Holders Change %
+40.43%
% of All Funds
1.16%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
29
Increased
17
Reduced
7
Closed
10
Calls
$1.15M
Puts
$810K
Net Calls
+$337K
Net Calls Change
+$337K

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$29.3M
2
PA
Perceptive Advisors
New York
+$21.2M
3
RSCM
Rock Springs Capital Management
Maryland
+$15.9M
4
SCM
Suvretta Capital Management
New York
+$12.8M
5
Millennium Management
Millennium Management
New York
+$8.58M

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$5.93M
2
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$5.62M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$4M
4
TLP
Tri Locum Partners
New York
-$2.61M
5
Holocene Advisors
Holocene Advisors
New York
-$2.07M
Name Holding Trade Value Shares
Change 		Change in
Stake
Primecap Management
26
Primecap Management
California
$1.65M – – –
Renaissance Technologies
27
Renaissance Technologies
New York
$900K -$325K -92,000 -26%
DMPV
28
Delphi Management Partners VIII
California
$865K – – –
IA
29
Insight Advisors
Pennsylvania
$812K +$808K +228,725 New
SCM
30
Silverarc Capital Management
Massachusetts
$590K -$371K -105,000 -38%
HM
31
HealthCor Management
New York
$503K +$527K +149,170 New
BFM
32
Boothbay Fund Management
New York
$499K +$70.7K +20,000 +16%
Qube Research & Technologies (QRT)
33
Qube Research & Technologies (QRT)
United Kingdom
$485K +$509K +143,967 New
IC
34
Ikarian Capital
Texas
$419K – – –
PVI
35
Pura Vida Investments
New York
$339K +$355K +100,514 New
Creative Planning
36
Creative Planning
Kansas
$267K +$280K +79,169 New
Barclays
37
Barclays
United Kingdom
$266K +$279K +78,988 New
PCS
38
Personal CFO Solutions
New Jersey
$252K +$264K +74,776 New
Marshall Wace
39
Marshall Wace
United Kingdom
$248K +$260K +73,558 New
AI
40
Atom Investors
Texas
$222K +$233K +65,924 New
JGC
41
J. Goldman & Co
New York
$212K -$1.4M -397,284 -86%
HSBC Holdings
42
HSBC Holdings
United Kingdom
$196K – – –
Jane Street
43
Jane Street
New York
$159K +$85.5K +24,181 +105%
Morgan Stanley
44
Morgan Stanley
New York
$149K +$141K +39,971 +975%
Geode Capital Management
45
Geode Capital Management
Massachusetts
$111K +$117K +32,987 New
Squarepoint
46
Squarepoint
New York
$60K +$62.6K +17,699 New
SC
47
Shay Capital
New York
$58K -$525K -148,544 -90%
Susquehanna International Group
48
Susquehanna International Group
Pennsylvania
$54K +$56.4K +15,954 New
RJA
49
Raymond James & Associates
Florida
$51K +$53.3K +15,089 New
WANY
50
Wealthspire Advisors (New York)
New York
$48K – – –
1
2
3 4

MREO Hedge Fund Activity: Q1 2021 in Review

66 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Mereo BioPharma (MREO) for Q1 2021, worth a combined $305M — up 49% from $205M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new MREO positions and 10 closed out — a net gain of 19 holders — while 17 added to existing stakes and 7 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $29.3M. The largest seller was Citadel Advisors, cutting an estimated $5.93M.

  • 66 institutional investors held Mereo BioPharma (MREO) as of Q1 2021, up from 47 in Q4 2020.
  • Funds reported $305M of Mereo BioPharma stock for Q1 2021, up 49% quarter-over-quarter.
  • 29 funds opened new Mereo BioPharma positions in Q1 2021 and 10 closed out, a net change of +19 holders.
  • The largest Mereo BioPharma buyer in Q1 2021 was Point72 Asset Management, an estimated $29.3M added.
  • The largest Mereo BioPharma seller in Q1 2021 was Citadel Advisors, an estimated $5.93M sold.

Based on aggregated 13F filings for Q1 2021.